These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11498774)

  • 1. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype.
    Krueger S; Kellner U; Buehling F; Roessner A
    Cancer Gene Ther; 2001 Jul; 8(7):522-8. PubMed ID: 11498774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
    Krueger S; Haeckel C; Buehling F; Roessner A
    Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense inhibition of urokinase: effect on malignancy in a human osteosarcoma cell line.
    Haeckel C; Krueger S; Roessner A
    Int J Cancer; 1998 Jul; 77(1):153-60. PubMed ID: 9639407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer cells express cathepsins B and L but not cathepsins K or H.
    Ishibashi O; Mori Y; Kurokawa T; Kumegawa M
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):69-78. PubMed ID: 10738903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
    Colella R; Jackson T; Goodwyn E
    Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis.
    Husmann K; Muff R; Bolander ME; Sarkar G; Born W; Fuchs B
    Mol Carcinog; 2008 Jan; 47(1):66-73. PubMed ID: 17683065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
    Colella R; Casey SF
    Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
    Zajc I; Sever N; Bervar A; Lah TT
    Cancer Lett; 2002 Dec; 187(1-2):185-90. PubMed ID: 12359367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
    Gopal P; Rehman RU; Chadha KS; Qiu M; Colella R
    Oncol Rep; 2006 Aug; 16(2):313-20. PubMed ID: 16820909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.
    Cuvier C; Jang A; Hill RP
    Clin Exp Metastasis; 1997 Jan; 15(1):19-25. PubMed ID: 9009102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cathepsins B and L in human lung epithelial cells is regulated by cytokines.
    Gerber A; Welte T; Ansorge S; Bühling F
    Adv Exp Med Biol; 2000; 477():287-92. PubMed ID: 10849756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells.
    Gerber A; Wille A; Welte T; Ansorge S; Bühling F
    J Interferon Cytokine Res; 2001 Jan; 21(1):11-9. PubMed ID: 11177576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.
    Levicar N; Dewey RA; Daley E; Bates TE; Davies D; Kos J; Pilkington GJ; Lah TT
    Cancer Gene Ther; 2003 Feb; 10(2):141-51. PubMed ID: 12536203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antisense inhibition of urokinase in a human osteosarcoma cell line].
    Haeckel C; Krueger S; Roessner A
    Verh Dtsch Ges Pathol; 1998; 82():170-7. PubMed ID: 10095429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intracellular form of cathepsin B contributes to invasiveness in cancer.
    Szpaderska AM; Frankfater A
    Cancer Res; 2001 Apr; 61(8):3493-500. PubMed ID: 11309313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells.
    Kirschke H; Eerola R; Hopsu-Havu VK; Brömme D; Vuorio E
    Eur J Cancer; 2000 Apr; 36(6):787-95. PubMed ID: 10762753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.
    Navab R; Mort JS; Brodt P
    Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.
    Kido A; Krueger S; Haeckel C; Roessner A
    Clin Exp Metastasis; 2003; 20(7):585-92. PubMed ID: 14669789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of cathepsin L in metastatic bone tumors.
    Park IC; Lee SY; Jeon DG; Lee JS; Hwang CS; Hwang BG; Lee SH; Hong WS; Hong SI
    J Korean Med Sci; 1996 Apr; 11(2):144-8. PubMed ID: 8835762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
    Colella R; Goodwyn E; Gopal P
    Cancer Lett; 2002 Nov; 185(2):163-72. PubMed ID: 12169390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.